Protagonist Therapeutics, Inc

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. PTGX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/12/2026

Shares

571,825

Value ($000)

60,270

Weight

5.1%

2025 Q4 - 2026 Q1 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/12/2026	60,270	5.1%	571,825	3/31/2026
2025 Q4	2/11/2026	49,943	4.4%	571,825	12/31/2025